These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6214943)
21. Choline and lecithin administration to patients with tardive dyskinesia. Growdon JH; Gelenberg AJ Trans Am Neurol Assoc; 1978; 103():95-9. PubMed ID: 757093 [No Abstract] [Full Text] [Related]
22. Effects of physostigmine and lecithin on memory in Alzheimer disease. Peters BH; Levin HS Ann Neurol; 1979 Sep; 6(3):219-21. PubMed ID: 534419 [TBL] [Abstract][Full Text] [Related]
23. Do raised brain aluminium levels in Alzheimer's dementia contribute to cholinergic neuronal deficits? King RG Med Hypotheses; 1984 Jul; 14(3):301-6. PubMed ID: 6472159 [TBL] [Abstract][Full Text] [Related]
27. Chemotherapy of cognitive disorders in geriatric subjects. Goodnick P; Gershon S J Clin Psychiatry; 1984 May; 45(5):196-209. PubMed ID: 6327657 [TBL] [Abstract][Full Text] [Related]
28. Lecithin in the treatment of Gilles de la Tourette's syndrome. Moldofsky H; Sandor P Am J Psychiatry; 1983 Dec; 140(12):1627-9. PubMed ID: 6580827 [TBL] [Abstract][Full Text] [Related]
29. Choline in tardive dyskinesia and Huntington's disease. Davis KL; Hollister LE; Barchas JD; Berger PA Life Sci; 1976 Nov; 19(10):1507-15. PubMed ID: 136581 [No Abstract] [Full Text] [Related]
30. Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. Chung SY; Moriyama T; Uezu E; Uezu K; Hirata R; Yohena N; Masuda Y; Kokubu T; Yamamoto S J Nutr; 1995 Jun; 125(6):1484-9. PubMed ID: 7782901 [TBL] [Abstract][Full Text] [Related]
32. An update on the neurochemistry of Alzheimer disease. Davies P Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134 [No Abstract] [Full Text] [Related]
34. Treatment of tardive dyskinesia with lecithin. Jackson IV; Nuttall EA; Ibe IO; Perez-Cruet J Am J Psychiatry; 1979 Nov; 136(11):1458-60. PubMed ID: 40440 [TBL] [Abstract][Full Text] [Related]
35. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission. Amenta F; Tayebati SK; Vitali D; Di Tullio MA Mech Ageing Dev; 2006 Feb; 127(2):173-9. PubMed ID: 16297435 [TBL] [Abstract][Full Text] [Related]
36. Fluctuations of free choline levels in plasma of Alzheimer patients receiving lecithin: preliminary observations. Chuaqui P; Levy R Br J Psychiatry; 1982 May; 140():464-9. PubMed ID: 7049290 [TBL] [Abstract][Full Text] [Related]
37. Lecithin consumption increases acetylcholine concentrations in rat brain and adrenal gland. Hirsch MJ; Wurtman RJ Science; 1978 Oct; 202(4364):223-5. PubMed ID: 694529 [TBL] [Abstract][Full Text] [Related]
38. Cholinergic enhancement and REM sleep latency in the aged: lecithin does not reproduce physostigmine effect. Kapen S; Fleming PD; Drachman DA Neurology; 1986 Aug; 36(8):1079-83. PubMed ID: 3736870 [TBL] [Abstract][Full Text] [Related]
39. Oral choline administration to patients with tardive dyskinesia. Growdon JH; Hirsch MJ; Wurtman RJ; Wiener W N Engl J Med; 1977 Sep; 297(10):524-7. PubMed ID: 887103 [TBL] [Abstract][Full Text] [Related]
40. Precursor control of neurotransmitter synthesis. Wurtman RJ; Hefti F; Melamed E Pharmacol Rev; 1980 Dec; 32(4):315-35. PubMed ID: 6115400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]